General Information
Version
CAT 452 - Sodium valproate Assay Standard
Revision date
2021-10-06
Product name
Sodium valproate Assay Standard
Substance name
C8 H16 O2. Na 166.19 g/mol
CAS No.
1069-66-5
1.2.1 Relevant identified uses
Laboratory use
supplier name
British Pharmacopoeia Commission
Emergency telephone
+44 (0)20 3080 6561, (+352) 8002 5500
Icons in SDS
Company Information
company name
British Pharmacopoeia Commission
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H360, H360Df, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.2 Label elements
213-961-8
Contains
Sodium valproate
Signal word
Danger
Hazard statements
H302 - Harmful if swallowed H315 - Causes skin irritation H319 - Causes serious eye irritation H360 - May damage fertility or the unborn child H360Df - May damage the unborn child. Suspected of damaging fertility H373 - May cause damage to organs through prolonged or repeated exposure
Precautionary statements
P201 - Obtain special instructions before use P260 - Do not breathe dust/fume/gas/mist/vapours/spray P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P501 - Dispose of contents/ container to an approved waste disposal plant
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information Chemical name EU - REACH
